Author

Javier Gerardo Tartaglione

ORCID: 0000-0002-1326-8001

Observed ORCID: 0000-0002-1326-8001

OpenAlex ID: A5097247652

Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial

2021 · Peter G Kremsner, Rodolfo Andrés Ahuad Guerrero, et al. · The Lancet Infectious Diseases · 182

Works count: 1

Citation count: 182

H-index: 1

I10-index: 1